Filed: 5/15/2023ACC: 0001389933-23-000006
📋 What this filing means
DAFNA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 72 equity positions with a total reported market value of $333.54M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
72
Positions
$333.54M
Total AUM (reported)
37.69M
Total Shares
Allocation by class
COM$208.18M62.4%
ETF$56.68M17.0%
COM NEW$38.35M11.5%
SPONSORED ADR$14.50M4.3%
SHS NEW$3.43M1.0%
SPONSORED ADS$3.43M1.0%
SPON ADS$2.94M0.9%
Portfolio Concentration
Top 3$86.26M25.9%
4–10$87.28M26.2%
11–25$91.78M27.5%
Rest$68.22M20.5%
Top 3 weight
25.9%
Top 10 weight
52.0%
Voting Authority Distribution
Total shares with voting rights: 37.69M
Sole
Full voting authority
37.69M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole72
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings72
Rows:
SPDR S&P BIOTECH ETF
SOLEShares570K
TypeSH
Market value$43.44M
13.02%
Sole
570K
Shared
0.00
None
0.00
STEREOTAXIS INC
SOLEShares13.68M
TypeSH
Market value$27.91M
8.37%
Sole
13.68M
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares612.98K
TypeSH
Market value$14.91M
4.47%
Sole
612.98K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares135.21K
TypeSH
Market value$14.50M
4.35%
Sole
135.21K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares78.57K
TypeSH
Market value$14.27M
4.28%
Sole
78.57K
Shared
0.00
None
0.00
ISHARES NASDAQ BIOTECH INDX
SOLEShares102.50K
TypeSH
Market value$13.24M
3.97%
Sole
102.50K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares575.78K
TypeSH
Market value$12.47M
3.74%
Sole
575.78K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares261.24K
TypeSH
Market value$11.75M
3.52%
Sole
261.24K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares316.09K
TypeSH
Market value$11.31M
3.39%
Sole
316.09K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares276.50K
TypeSH
Market value$9.73M
2.92%
Sole
276.50K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares447.07K
TypeSH
Market value$9.44M
2.83%
Sole
447.07K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares67.55K
TypeSH
Market value$7.85M
2.35%
Sole
67.55K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares180.31K
TypeSH
Market value$7.57M
2.27%
Sole
180.31K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares74.61K
TypeSH
Market value$7.55M
2.26%
Sole
74.61K
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares179.47K
TypeSH
Market value$6.76M
2.03%
Sole
179.47K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares468.36K
TypeSH
Market value$6.43M
1.93%
Sole
468.36K
Shared
0.00
None
0.00
CARDIOVASCULAR SYSTEMS
SOLEShares286.99K
TypeSH
Market value$5.70M
1.71%
Sole
286.99K
Shared
0.00
None
0.00
DICE THERAPEUTICS INC
SOLEShares187.59K
TypeSH
Market value$5.37M
1.61%
Sole
187.59K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares319.15K
TypeSH
Market value$5.31M
1.59%
Sole
319.15K
Shared
0.00
None
0.00
MERUS N V
SOLEShares284K
TypeSH
Market value$5.23M
1.57%
Sole
284K
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares125.53K
TypeSH
Market value$5.20M
1.56%
Sole
125.53K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares566.70K
TypeSH
Market value$5.03M
1.51%
Sole
566.70K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares733.24K
TypeSH
Market value$4.89M
1.47%
Sole
733.24K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares616.03K
TypeSH
Market value$4.84M
1.45%
Sole
616.03K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares551.50K
TypeSH
Market value$4.60M
1.38%
Sole
551.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P BIOTECH ETFSOLE | ETF | 570K | SH | $43.44M 13.02% | 570K | 0.00 | 0.00 |
STEREOTAXIS INCSOLE | COM NEW | 13.68M | SH | $27.91M 8.37% | 13.68M | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 612.98K | SH | $14.91M 4.47% | 612.98K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 135.21K | SH | $14.50M 4.35% | 135.21K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 78.57K | SH | $14.27M 4.28% | 78.57K | 0.00 | 0.00 |
ISHARES NASDAQ BIOTECH INDXSOLE | ETF | 102.50K | SH | $13.24M 3.97% | 102.50K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 575.78K | SH | $12.47M 3.74% | 575.78K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 261.24K | SH | $11.75M 3.52% | 261.24K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 316.09K | SH | $11.31M 3.39% | 316.09K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 276.50K | SH | $9.73M 2.92% | 276.50K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 447.07K | SH | $9.44M 2.83% | 447.07K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 67.55K | SH | $7.85M 2.35% | 67.55K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | COM | 180.31K | SH | $7.57M 2.27% | 180.31K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 74.61K | SH | $7.55M 2.26% | 74.61K | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 179.47K | SH | $6.76M 2.03% | 179.47K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 468.36K | SH | $6.43M 1.93% | 468.36K | 0.00 | 0.00 |
CARDIOVASCULAR SYSTEMSSOLE | COM | 286.99K | SH | $5.70M 1.71% | 286.99K | 0.00 | 0.00 |
DICE THERAPEUTICS INCSOLE | COM | 187.59K | SH | $5.37M 1.61% | 187.59K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 319.15K | SH | $5.31M 1.59% | 319.15K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 284K | SH | $5.23M 1.57% | 284K | 0.00 | 0.00 |
ATRICURE INCSOLE | COM | 125.53K | SH | $5.20M 1.56% | 125.53K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 566.70K | SH | $5.03M 1.51% | 566.70K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 733.24K | SH | $4.89M 1.47% | 733.24K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 616.03K | SH | $4.84M 1.45% | 616.03K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 551.50K | SH | $4.60M 1.38% | 551.50K | 0.00 | 0.00 |
Page 1 of 3